Markets
BSE See NSE See 36,594.33
-143.36 (-0.39%)

Alembic Pharmaceuticals Ltd. Industry : (Pharmaceuticals)

Quick Glance

Listed on BSE and NSE
  • Market Cap 17,734Crores
  • Book Value 171
  • Face Value 2
  • Current Price 940.70
  • % Change 1.07
  • 52 week H/L 984/ 436
  • TTM P/E 22.14
  • Dividend Yield 1 %

Stock vs. Index

Alembic Phar
Sensex

Historical Return

1 Yr (%) 2 Yr (%) 3 Yr (%) 4 Yr (%) 5 Yr (%)
80.16 81.87 82.27 57.07 23.60

ROCE Vs RONW

ROCE
RONW

Price History

You can view historic prices (Open,High,Low,Close) of the company for the range of days

Company
Analysis

This Company From The Pharmaceutical Sector Is Right Prescription For The Health Of Your Portfolio

Sep 27, 2018

This section covers a stock which has been in buzz for the past couple of m


Shareholding Pattern

Company Research

Company NameReco DateReco PriceView Report
Alembic Pharmaceuticals Ltd. 14/08/2019523.00 View

collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Dec 17 Mar 18 Jun 18 Dec 18 Mar 19 Jun 19 Sep 19 Dec 19 Mar 20
Sales 754.91 838.22 811.42 904.72 848.70 896.74 1134.90 1052.36 1048.56
Other Income 0.32 0.28 0.16 3.36 0.89 3.18 0.28 0.29 131.01
Operating Profit 160.47 206.79 171.58 205.05 153.02 224.78 360.73 321.11 296.26
Interest 0.64 0.64 1.10 4.62 4.34 4.66 6.63 6.93 6.97
Depreciation 26.38 27.92 25.34 26.56 27.49 32.50 32.51 34.31 36.35
Taxation 28.73 34.32 31.32 38.72 14.42 35.58 53.18 48.97 59.65
Net Profit / Loss 105.04 144.19 113.98 138.51 107.66 155.22 268.69 231.19 314.30

Annual Results

(All figures In Rs. Cr.) Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18 Mar 19 Mar 20
Sales 1370.20 1491.63 1839.54 2011.04 2991.74 2956.45 2945.26 3660.27 4132.55
Other Income 0.44 3.93 3.19 0.57 5.51 2.42 6.67 6.42 134.75
Operating Profit 209.58 243.76 359.02 410.91 982.01 633.28 632.53 878.67 1202.90
Interest 26.21 14.57 9.81 1.11 2.36 3.09 2.22 14.87 25.19
Depreciation 33.65 34.96 40.49 44.41 71.86 82.90 101.76 105.59 135.67
Taxation 29.62 40.71 73.63 76.25 215.17 119.08 113.23 153.42 197.39
Net Profit / Loss 120.54 157.45 238.28 286.61 698.13 430.63 421.99 611.21 969.40

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM 21.44% 92.21%
1 Years 12.90% 58.60%
2 Years 18.45% 51.57%
3 Years 11.81% 31.06%
4 Years 8.41% 8.55%
5 Years 15.49% 27.60%

Investor Returns

Type Ratio / % Date
Dividend
350.00
16 Mar 2020

Announcements

Date Title
Jul 08, 2020 Alembic Pharmaceutic - Loss of Share Certificates
Jul 07, 2020 Alembic Pharmaceutic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 06, 2020 Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jul 01, 2020 Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets
Jun 22, 2020 Alembic Pharma attains new lifetime high

collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
493.45
2.36%
118,395.18
512.55 / 315.20
188.65
28.38
Dr. Reddy's Laboratories Ltd.
3,902.10
0.06%
64,865.59
4,189.35 / 2,352.00
938.37
32.02
Divi's Laboratories Ltd.
2,207.00
1.30%
58,588.92
2,537.70 / 1,466.95
275.36
42.56
Cipla Ltd.
638.65
-0.02%
51,492.50
696.00 / 356.75
195.51
33.30
Biocon Ltd.
414.30
2.02%
49,716.00
420.35 / 211.30
55.88
66.45
Aurobindo Pharma Ltd.
820.50
0.97%
48,076.26
828.45 / 281.15
286.90
16.98
Torrent Pharmaceuticals Ltd.
2,352.75
-0.45%
39,813.88
2,679.45 / 1,453.00
285.05
38.84
Lupin Ltd.
860.75
-0.77%
38,999.81
955.85 / 505.00
276.69
0.00
Cadila Healthcare Ltd.
356.95
0.27%
36,542.49
383.65 / 206.45
101.35
31.06
Abbott India Ltd.
15,511.05
-0.19%
32,959.90
18,569.00 / 8,299.80
1,144.37
55.59